Genevive Hernandez

Atezolizumab in combination with bevacizumab enhances antigen-specific T-cell migration in metastatic renal cell carcinoma

Jeffrey J. Wallin, Johanna C. Bendell, Roel Funke et al. · Nature Communications · 2016 · 690 citations · Full text

Tumor Biology, Tumor Immunology, Cancer Immunosurveillance +14

Atezolizumab plus cobimetinib and vemurafenib in BRAF-mutated melanoma patients

Ryan J. Sullivan, Omid Hamid, René González et al. · Nature Medicine · 2019 · 233 citations

Medicine, Melanoma, Braf-mutated Melanoma Patients +4

Phase Ib study of atezolizumab combined with cobimetinib in patients with solid tumors

Matthew D. Hellmann, T. W. Kim, Chul‐min Lee et al. · Annals of Oncology · 2019 · 188 citations · Full text

Phase Ib Study, Solid Tumors, Medicine +7

Mosunetuzumab Induces Complete Remissions in Poor Prognosis Non-Hodgkin Lymphoma Patients, Including Those Who Are Resistant to or Relapsing After Chimeric Antigen Receptor T-Cell (CAR-T) Therapies, and Is Active in Treatment through Multiple Lines

Stephen J. Schuster, Nancy L. Bartlett, Sarit Assouline et al. · Blood · 2019 · 179 citations

Anti-VEGF Treatment Enhances CD8+ T-cell Antitumor Activity by Amplifying Hypoxia

Patricia E. de Almeida, Judy Mak, Genevive Hernandez et al. · Cancer Immunology Research · 2020 · 97 citations